Director Christopher R. Reidy Acquires Shares in Encompass Health via Deferred Compensation Plan

Executive Summary

On October 19, 2026, Encompass Health Corp ($EHC) director Christopher R. Reidy reported acquisitions of common stock totaling 304 shares, bringing his total direct beneficial ownership to 18,081 shares.

Transaction Breakdown

1. October 15, 2026 (Dividend Equivalent RSUs):

   • Shares Acquired: 20
   • Price Per Share: $0.00
   • Nature: Additional restricted stock units credited in connection with the company's quarterly common stock dividend ($0.21 per share).

2. October 19, 2026 (Directors Deferred Stock Investment Plan):

   • Shares Acquired: 284
   • Price Per Share: $126.89 (weighted average; range: $126.83 to $126.89)
   • Total Consideration: $36,036.76
   • Nature: Purchased via the plan administrator using deferred director fees and reinvested dividends.

Market Impact & Significance

This filing carries Low trading significance as it represents standard corporate governance and compensation mechanisms rather than a discretionary, open-market insider purchase. The transactions were executed pursuant to predetermined elections under the company's non-qualified deferred compensation plan and standard dividend-equivalent RSU terms.